Tailor-made cleavage site attenuates influenza B

Xavier Saelens1

  • 1Department for Molecular Biomedical Research, VIB, 9000 Ghent, Belgium. xavier.saelens@dmbr.vib-ugent.be

Expert Review of Vaccines
|February 8, 2012
PubMed
Summary

A novel live-attenuated influenza B vaccine candidate, dependent on elastase for hemagglutinin maturation, shows strong attenuation in mice but induces robust immunity. This approach offers a promising strategy for improved influenza B vaccines.